Halozyme Therapeutics Inc (FRA:RV7)
€ 45.9 0.41 (0.9%) Market Cap: 5.88 Bil Enterprise Value: 6.68 Bil PE Ratio: 15.94 PB Ratio: 13.52 GF Score: 85/100

Halozyme Therapeutics Inc Annual Shareholders Meeting Transcript

Apr 30, 2020 / 03:00PM GMT
Release Date Price: €21.6 (+0.93%)
Operator

Good morning, ladies and gentlemen, and welcome to today's meeting. It is now my pleasure to turn the floor over to your host, Dr. Helen Torley. Ma'am, the floor is yours.

Helen I. Torley
Halozyme Therapeutics, Inc. - President, CEO & Director

Good morning, everyone. My name is Helen Torley, I'm the President and Chief Executive Officer of Halozyme Therapeutics, and I'll be chairing this Annual Meeting of Stockholders.

As mentioned in our supplementary proxy materials, due to the public health impact of COVID-19, we're hosting a virtual shareholder meeting this year to support the health and well-being of our stockholders, the employees and also to comply with the state of California's stay-at-home order.

I'd like to call this meeting to order. The meeting is being held pursuant to the Notice of the Annual Meeting mailed to all of the company's stockholders on or about March 20, 2020.

The polls are now open. And at this time, any stockholders who are present and who would like to vote the shares of this meeting may do so by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot